Search Results - "Maderdrut, Jerome L"

Refine Results
  1. 1

    A structure–function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists by Ramos-Álvarez, Irene, Mantey, Samuel A., Nakamura, Taichi, Nuche-Berenguer, Bernardo, Moreno, Paola, Moody, Terry W., Maderdrut, Jerome L., Coy, David H., Jensen, Robert T.

    Published in Peptides (New York, N.Y. : 1980) (01-04-2015)
    “…•46 PACAP analogs were synthesized with conformationally restricted substitutions.•Their pharmacology (affinity and potency) was determined for VPAC1R, VPAC2R…”
    Get full text
    Journal Article
  2. 2

    Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury by Li, Min, Balamuthusamy, Saravanan, Khan, Altaf M., Maderdrut, Jerome L., Simon, Eric E., Batuman, Vecihi

    Published in Peptides (New York, N.Y. : 1980) (01-04-2010)
    “…Cisplatin nephrotoxicity involves DNA damage, proinflammatory responses and apoptosis/necrosis of renal proximal tubular epithelial cells. Pituitary adenylate…”
    Get full text
    Journal Article
  3. 3

    Renoprotection by pituitary adenylate cyclase-activating polypeptide in multiple myeloma and other kidney diseases by Li, Min, Maderdrut, Jerome L., Lertora, Juan J.L., Arimura, Akira, Batuman, Vecihi

    Published in Regulatory peptides (10-01-2008)
    “…Renal involvement in patients with multiple myeloma complicates their treatment and shortens their life-span. The main renal lesion is a tubulointerstitial…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Pituitary Adenylate Cyclase-Activating Polypeptide Prevents Cisplatin-Induced Renal Failure by Li, Min, Balamuthusamy, Saravanan, Khan, Altaf M., Maderdrut, Jerome L., Simon, Eric E., Batuman, Vecihi

    Published in Journal of molecular neuroscience (01-01-2011)
    “…Cisplatin is widely used for cancer chemotherapy, but nephrotoxicity is a major dose-limiting side effect. Our recent studies in vitro have shown that…”
    Get full text
    Journal Article
  5. 5

    The effect of PACAP38 on MyD88-mediated signal transduction in ischemia-/hypoxia-induced acute kidney injury by Li, Min, Khan, Altaf-M, Maderdrut, Jerome L, Simon, Eric E, Batuman, Vecihi

    Published in American journal of nephrology (01-01-2010)
    “…toll-like receptor 4 (TLR4) and its adaptor protein MyD88 play an important role in ischemia/reperfusion (I/R) injury in the kidney, and pituitary adenylate…”
    Get more information
    Journal Article
  6. 6

    Pituitary adenylate cyclase-activating polypeptide is a potent broad-spectrum antimicrobial peptide: Structure-activity relationships by Starr, Charles G., Maderdrut, Jerome L., He, Jing, Coy, David H., Wimley, William C.

    Published in Peptides (New York, N.Y. : 1980) (01-06-2018)
    “…•PACAP38 has broad spectrum antimicrobial activity.•Full length agonist and antagonist variants retain antimicrobial activity.•Receptor activation and…”
    Get full text
    Journal Article
  7. 7

    Distribution of urocortin-like immunoreactivity in the central nervous system of the frog Rana esculenta by Kozicz, Tamás, Arimura, Akira, Maderdrut, Jerome L., Lázár, Gyula

    Published in Journal of comparative neurology (1911) (11-11-2002)
    “…Corticotropin‐releasing factor (CRF), sauvagine, and urotensin I are all members of the so‐called CRF neuropeptide family. Urocortin (Ucn), a 40‐amino‐acid…”
    Get full text
    Journal Article
  8. 8

    Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice by Subramaniam, Venkat, Chuang, Gin, Xia, Huijing, Burn, Brendan, Bradley, Jessica, Maderdrut, Jerome L., Coy, David H., Varner, Kurt J.

    Published in Peptides (New York, N.Y. : 1980) (01-09-2017)
    “…•Treatment with mitoxantrone once a week caused a dilated cardiomyopathy in mice.•Treatment with mitoxantrone once a week caused a large loss of body weight in…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Intravenous infusion of pituitary adenylate cyclase-activating polypeptide (PACAP) in a patient with multiple myeloma and myeloma kidney: A case study by Li, Min, Maderdrut, Jerome L., Lertora, Juan J.L., Batuman, Vecihi

    Published in Peptides (New York, N.Y. : 1980) (01-09-2007)
    “…We have recently shown significant renoprotective effects with the administration of pituitary adenylate cyclase-activating polypeptide (PACAP) in models of…”
    Get full text
    Journal Article
  11. 11

    Delayed administration of pituitary adenylate cyclase-activating polypeptide 38 ameliorates renal ischemia/reperfusion injury in mice by modulating Toll-like receptors by Khan, Altaf-M., Li, Min, Abdulnour-Nakhoul, Solange, Maderdrut, Jerome L., Simon, Eric E., Batuman, Vecihi

    Published in Peptides (New York, N.Y. : 1980) (01-12-2012)
    “…► Bilateral renal ischemia/reperfusion (IR) induced kidney injury in mice. ► IR activated Toll-like receptors (TLRs). ► TLRs induced inflammatory cytokine…”
    Get full text
    Journal Article
  12. 12

    Renoprotection With Pituitary Adenylate Cyclase-Activating Polypeptide in Cyclosporine A-Induced Nephrotoxicity by Khan, Altaf-M, Li, Min, Brant, Elizabeth, Maderdrut, Jerome L., Majid, Dewan S.A., Simon, Eric E., Batuman, Vecihi

    Published in Journal of investigative medicine (01-06-2011)
    “…BackgroundAcute and long-term nephrotoxicity is the major dose-limiting factor for cyclosporine A (CsA). We evaluated the protective effects of pituitary…”
    Get full text
    Journal Article
  13. 13

    Myeloma light chain-induced renal injury in mice by Khan, Altaf-M, Li, Min, Balamuthusamy, Saravanan, Maderdrut, Jerome L, Simon, Eric E, Batuman, Vecihi

    Published in Nephron. Experimental nephrology (01-01-2010)
    “…We investigated the effects of human light chain (LC) protein-overload in mice kidney to gain further insights into the molecular mechanisms involved in the…”
    Get more information
    Journal Article
  14. 14

    Pituitary adenylate cyclase‐activating polypeptide prevents contrast‐induced nephropathy in a novel mouse model by Khan, Altaf‐M., Maderdrut, Jerome L., Li, Min, Toliver, Herman L., Coy, David H., Simon, Eric E., Batuman, Vecihi

    Published in Physiological reports (01-11-2013)
    “…We determined whether pituitary adenylate cyclase‐activating polypeptide 38 (PACAP38) prevents contrast‐induced nephropathy using human renal proximal tubule…”
    Get full text
    Journal Article
  15. 15

    Neuroprotective Effects of PACAP38 in a Rat Model of Transient Focal Ischemia under Various Experimental Conditions by REGLODI, DORA, SOMOGYVARI-VIGH, ANIKO, VIGH, SANDOR, MADERDRUT, JEROME L., ARIMURA, AKIRA

    Published in Annals of the New York Academy of Sciences (01-12-2000)
    “…: In the study reported here, we investigated the neuroprotective effect of PACAP38 in a rat model of middle cerebral artery occlusion (MCAO) under various…”
    Get full text
    Journal Article
  16. 16

    Filament size influences temperature changes and brain damage following middle cerebral artery occlusion in rats by ABRAHAM, Hajnalka, SOMOGYVARI-VIGH, Aniko, MADERDRUT, Jerome L, VIGH, Sandor, ARIMURA, Akira

    Published in Experimental brain research (2002)
    “…Postischemic spontaneous hyperthermia as a complication of occlusion of the middle cerebral artery with an intraluminal filament has been observed by some…”
    Get full text
    Journal Article
  17. 17

    Distribution of melanin-concentrating hormone-like immunoreactivity in the central nervous system of Rana esculenta by Lázár, Gyula, Maderdrut, Jerome L, Merchenthaler, Istvan

    Published in Brain research bulletin (01-02-2002)
    “…The distribution of salmon and rat melanin-concentrating hormone (MCH)-like and neuropeptide glutamate-isoleucine (NEI)-like immunoreactivity in the brain and…”
    Get full text
    Journal Article Conference Proceeding
  18. 18

    In situ hybridization histochemical localization of prodynorphin messenger RNA in the central nervous system of the rat by Merchenthaler, István, Maderdrut, Jerome L., Cianchetta, Paul, Shughrue, Paul, Bronstein, David

    Published in Journal of comparative neurology (1911) (28-07-1997)
    “…The distribution of preprodynorphin messenger RNA‐containing perikarya in the central nervous system of the rat was determined with in situ hybridization…”
    Get full text
    Journal Article
  19. 19

    Rapidly activated microglial cells in the preoptic area may play a role in the generation of hyperthermia following occlusion of the middle cerebral artery in the rat by ABRAHAM, Hajnalka, SOMOGYVARI-VIGH, Aniko, MADERDRUT, Jerome L, VIGH, Sandor, ARIMURA, Akira

    Published in Experimental brain research (01-11-2003)
    “…Postischemic hyperthermia occurs after the occlusion of the middle cerebral artery (MCAO) with an intraluminal filament in rats. The cause of hyperthermia is…”
    Get full text
    Journal Article
  20. 20

    Distribution of proneuropeptide Y-derived peptides in the brain of Rana esculenta and Xenopus laevis by Lázár, G, Maderdrut, J L, Trasti, S L, Liposits, Z, Tóth, P, Kozicz, T, Merchenthaler, I

    Published in Journal of comparative neurology (1911) (22-01-1993)
    “…The distribution of proneuropeptide Y-containing perikarya and nerve fibers in the brain of Rana esculenta and Xenopus laevis was determined with antisera…”
    Get more information
    Journal Article